PORTON ADVANCED SOLUTIONS
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
PORTON ADVANCED SOLUTIONS
Social Links:
Industry:
Biotechnology Genetics Manufacturing Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.portonadvanced.com
Total Employee:
101+
Status:
Active
Contact:
512-88850572
Email Addresses:
[email protected].
Total Funding:
141.34 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Content Delivery Network SSL By Default
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
GenEdit
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Investors List
China Merchants Group
China Merchants Group investment in Series B - Porton Advanced Solutions
HM Capital
HM Capital investment in Series B - Porton Advanced Solutions
China Merchants Health
China Merchants Health investment in Series B - Porton Advanced Solutions
Gortune Investment
Gortune Investment investment in Series B - Porton Advanced Solutions
China Merchants Securities
China Merchants Securities investment in Series B - Porton Advanced Solutions
Ruilin Investment
Ruilin Investment investment in Series B - Porton Advanced Solutions
SDICTK
SDICTK investment in Series B - Porton Advanced Solutions
CS Capital
CS Capital investment in Series B - Porton Advanced Solutions
Porton Pharma Solutions
Porton Pharma Solutions investment in Series B - Porton Advanced Solutions
Fosun Capital
Fosun Capital investment in Series B - Porton Advanced Solutions
Official Site Inspections
http://www.portonadvanced.com
- Host name: vps25437.dreamhostps.com
- IP address: 173.236.213.116
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Porton Advanced Solutions"
About Us - Porton Advanced
Porton Advanced Solutions (Porton Advanced) is a CRO and CDMO. We provide end-to-end research, process development (PD), analytical development (AD), GMP manufacturing, and testing services to meet clientsโ therapeutic product โฆSee details»
Porton Advanced โ Cell & Gene Therapy CDMO/CRO | LinkedIn
Porton Advanced is a Cell and Gene Therapy (CGT) CDMO/CRO. We provide end-to-end research grade, process development (PD), analytical development (AD), GMP โฆSee details»
Porton Advanced Solutions - Crunchbase Company Profile
Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.See details»
Process Development - Porton Advanced
Effective and efficient technology transfer is key to the success of CDMOs. At Porton Advanced, we have an established tech transfer process in which we take a stepwise approach, starting โฆSee details»
Porton Advanced - Overview, News & Similar companies - ZoomInfo
Jun 25, 2024 Explore Complete Organization Structure. Is Porton Advanced your ideal costumer? Let us give you the heads up on whether it's a good time to reach out ... Phone โฆSee details»
Porton Advanced Solution Ltd - Company Profile and News
Porton Advanced Solution Ltd. operates as a cell and gene therapy (CGT) contract development and manufacruring organization (CDMO). The Company offers end-to-end process โฆSee details»
Porton Advanced Solutions, LLC | Scientist.com
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the โฆSee details»
Porton Advanced - Craft
Porton Advanced has 5 employees across 3 locations and $80 m in total funding,. See insights on Porton Advanced including office locations, competitors, revenue, financials, executives, โฆSee details»
Porton Advanced โ Cell & Gene Therapy CDMO/CRO | ้ข่ฑ - ้ข่ฑ โฆ
Porton Advanced โ Cell & Gene Therapy CDMO/CRO | ๅจ้ข่ฑไธๆ 1,535 ไฝๅ ณๆณจ่ ใEnd-to-end cell & gene therapy CDMO/CRO that provides innovative offerings at each stage for โฆSee details»
Porton Advanced Solutions - VentureRadar
Similar Companies: Boston Institute of Biotechnology USA Privately Held As a contract research and development organization (CRDO), Boston Institute of Biotechnology, LLC, provides full โฆSee details»
Porton Advanced and Ascle Therapeutics Reached a Strategic โฆ
/PRNewswire/ -- On November 20, 2023, Porton Advanced announced a strategic partnership with Ascle Therapeutics to jointly develop and produce NK cells, assist...See details»
Porton Advanced Announces a Strategic Partnership with BioMap, โฆ
SUZHOU, China, Nov. 8, 2023 /PRNewswire/ -- On November 8, 2023, Porton Advanced announced the establishment of a strategic partnership with BioMap.BioMap will leverage โฆSee details»
Contact us - Porton Advanced
[email protected]. Get Directions. CRO/CDMO Inquiry. Use the form below to reach out to us. Weโll get back to you as soon as possible. Cranbury Campus. Main Office 6 Cedarbrook โฆSee details»
Quality Systems - Porton Advanced
Our Quality Management System (QMS) ensures that our quality system complies with FDA, EU and NMPA GMP requirement regarding material & supplier management, manufacturing โฆSee details»
Porton Advanced Announces a Strategic Partnership with BioMap, โฆ
SUZHOU, China, Nov. 8, 2023 /PRNewswire/ -- On November 8, 2023, Porton Advanced announced the establishment of a strategic partnership with BioMap.BioMap will leverage โฆSee details»
Testing Services - Porton Advanced
Our comprehensive testing services cover a wide range of functional platforms, including physicochemical, characterization, molecular, microbiology, biochemical, cel functional, and โฆSee details»
Porton Advanced introduces the MaxCyte ExPERT GTx Flow โฆ
SUZHOU, China, June 25, 2024 /PRNewswire/ -- Porton Advanced recently introduced the MaxCyte cGMP-grade ExPERT GTx Flow Electroporation instrument to its cell therapy โฆSee details»
Porton Advanced Solutions completes a Series B financing round โฆ
SUZHOU, China, Aug. 21, 2022 /PRNewswire/ -- On August 19, 2022, Porton Advanced Solutions (Porton Advanced) announced the completion of its Series B financing round with โฆSee details»
Company News Archives - Porton Advanced
Nov 14, 2024 About Us Menu Toggle. Contact us; Jobs; News; Events; Research & Preclinical Menu Toggle. Vector Cloning / Plasmid Service Menu Toggle. Vector Cloning Services; โฆSee details»